Showing results (1171-1180 of 6,956) with videos related to
Sort By:
Pageof 696
Journal of Clinical Pharmacology|November 18, 2020
Model-Informed Dose Optimization in PregnancyNupur Chaphekar, Steve Caritis, Raman VenkataramananJournal of Clinical Pharmacology|November 18, 2020
Chimeric Antigen Receptor T Cell Therapies: A Review of Cellular Kinetic-Pharmacodynamic Modeling ApproachesAnwesha Chaudhury, Xu Zhu, Lulu Chu, et al.Journal of Clinical Pharmacology|January 1, 1979
The metabolism of floctafenin in man and rodentsR K Lynn, R Holm, B N Swanson, et al.Journal of Clinical Pharmacology|January 1, 1979
Relative systemic availability of sulfapyridine from commercial enteric-coated and uncoated sulfasalazine tabletsH J Pieniaszek, D E Resetarits, W W Wilferth, et al.Journal of Clinical Pharmacology|February 22, 2020
Pharmacokinetic/Pharmacodynamic Analysis of Daptomycin Against Staphylococcus aureus and Enterococcus faecium in Pediatric Patients by Monte Carlo SimulationXiao-Chen Wei, Ming-Feng Zhao, Xin Li, et al.Journal of Clinical Pharmacology|February 7, 2020
A Drug-Drug Interaction Study to Evaluate the Effect of TAS-303 on CYP3A Activity in the Small Intestine and LiverYuji Kumagai, Tomoe Fujita, Mika Maeda, et al.Journal of Clinical Pharmacology|March 10, 2020
Cetirizine Reduces Gabapentin Plasma Concentrations and Effect: Role of Renal Drug Transporters for Organic CationsAna Carolina Conchon Costa, Priscila Akemi Yamamoto, Gabriela Rocha Lauretti, et al.Journal of Clinical Pharmacology|March 3, 2020
Population Pharmacokinetics and Pharmacodynamics of Ontamalimab (SHP647), a Fully Human Monoclonal Antibody Against Mucosal Addressin Cell Adhesion Molecule-1 (MAdCAM-1), in Patients With Ulcerative Colitis or Crohn's DiseaseYi Wang, Jean-Francois Marier, Jean Lavigne, et al.Journal of Clinical Pharmacology|June 11, 2021
Pharmacokinetics of Asciminib in Individuals With Hepatic or Renal ImpairmentMatthias Hoch, Masahiko Sato, Julia Zack, et al.Journal of Clinical Pharmacology|January 17, 2014
A series of pharmacokinetic studies of ceftaroline fosamil in select populations: normal subjects, healthy elderly subjects, and subjects with renal impairment or end-stage renal disease requiring hemodialysisTodd Riccobene, Abhijeet Jakate, Doug RankPageof 696